About Us
eversyn emerges from the Max Planck Institute Magdeburg, founded by scientists and business professionals associated with the Max Planck Society.
Our team features:
-
Diverse Backgrounds: An international group with varied skills and expertise
-
Research Output: Multiple patents and peer-reviewed publications
-
Collaborative Experience: Established partnerships and joint projects
-
Shared Vision: A commitment to translating scientific knowledge into practical solutions
We aim to bridge fundamental research and real-world applications, leveraging our collective experience in science and business.
Our team members
MANAGING DIRECTOR
Dr. Thomas Rexer
Thomas is dedicated to the development of our technology. He has written the prologue of success story as co-inventor of our IP portfolio. As team leader at the Max Planck Institute DCTS, Thomas has a proven track-record of building and leading a high-performance team in the field of biotechnology. Thomas earned a BSc in process engineering from the University of Stuttgart and an MSc from The University of Manchester. He earned his PhD from Newcastle University. In his free time, Thomas is an avid football player competing in the local football league.
CHIEF BUSINESS OFFICER
Rachel Thu Nguyen
Majored in entrepreneurship and innovation, Rachel manages the business development of our venture. Her key expertise belongs to sales and account management, marketing and human resources. Her experience varies from hi-tech unicorn to nutrition and medical device industry; and from Vietnam to Germany. Rachel is a Dean’s List Excellent Alumni of Otto-von-Guericke-University of Magdeburg, having graduated from the MSc program in International Management, Marketing, Entrepreneurship. Her hobbies include water-coloring and photographing.
PRINCIPAL SCIENTIST BIOCATALYSIS
Dr. Nam-Hai Hoang
Nam-Hai brings substantial experience in enzyme development, biocatalysis and reaction engineering for our production of human milk oligosaccharides. He is an enzymologist with solid experience using different classes of enzymes for organic synthesis and food processing. Nam-Hai studied his combined Master and PhD program in Bioengineering at Tokyo Institute of Technology with a Japanese government scholarship (MEXT), and won the Kamada-Izumi award from the university upon his doctoral dissertation completion. Before joining eversyn, he had two years working as a postdoc at Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB with the prestigious Alexander von Humboldt fellowship. In 2022, he was honourably selected as young scientist to participate in Lindau Nobel Laureate Meeting (Chemistry).
HEAD OF PRODUCTION
Sebastian Bruno Kleeberg
Sebastian is in charge of the production and quality of our nucleotide sugars. He is a specialist for the development of biocatalytic processes and microbial fermentation engineering. He has been essential for the development of our technology platform. Sebastian has earned a BSc from University of Applied Sciences Zittau/Görlitz in molecular biotechnology and is about to get an MSc from Bielefeld University. In his spare time, he serves for the German Army Reserve and loves to do functional fitness and hiking.
EXECUTIVE DIRECTOR STRATEGIC INITIATIVES
Dr. Daniel Last
Daniel oversees a wide range of strategic initiatives. He holds a diploma in biochemistry and a PhD in biocatalysis from the University of Greifswald, where he specialized in novel enzyme applications and protein engineering. During his postdoc at the Leibniz Institute for Natural Product Research and Infection Biology, he elucidated the biosynthesis of a cofactor and developed an urgently needed overproduction strains for it. Subsequently, he became project leader and scientist in the R&D department of the vaccine CDMO IDT Biologika, gaining valuable experience in the development of scalable and GMP-compliant processes. Daniel spends most of his free time with his family and friends, complemented by bouldering and reading news about innovations and start-ups.
SENIOR LAB MANAGER
.png)
Annika Deinert
Annika brings many years of professional experience as a laboratory technician, specializing in GMP-compliant quality control of medications at companies such as Sandoz and Torrent Pharma, as well as in vaccine development at IDT Biologika. In her current role, she focuses on the production, purification, and analysis of nucleotide sugars and oligosaccharides. Beyond her experimental work, she supports research staff in research and development projects and shares responsibility for the organization and management of the laboratory. In her free time, she enjoys spending time with her family, immersing herself in books, and practicing yoga.
Our advisor
Clinical Science Advisor, Immunology & Gut Health
Dr. Vassilis Triantis
Dr. Triantis brings deep expertise in Immunology, Gastrointestinal Physiology, and Molecular Biology, honed through academic training and over a decade in R&D nutrition. Combined with eversyn's proprietary cell‑free technology platform for producing complex oligosaccharides, this partnership accelerates our ability to generate rigorous experimental data, validate health benefits, and bring scientifically proven compounds to market.
Principal at ybe Berlin
Dr. rer. nat. Ursula La Cognata
Ursula is a passioned project manager with experience in research, food safety and regulatory affairs. Areas of expertise include GRAS, EFSA dossiers, medical foods, claim substantiation, labeling, regulatory due diligence, FDA food facility registration, clinical trial design and supervision. Well-founded knowledge of genetic engineering, registration of genetic engineering facilities, interaction with the authorities internationally, certified biosafety officer (BBS).
Principal at ybe Berlin
Dr. -Ing. Volker Landschütze
Volker started his career in food technology at the Institute for Genbiological Research in Berlin (IGF). After obtaining his PhD, he founded PlantTec Biotechnologie GmbH in Potsdam in 1996. The successful company finally became part of Bayer CropScience BioScience with around 100 employees at the site. During over 25 years of his professional career to date, he has successfully founded and managed start-ups and spent many years in a global corporation in management positions, including Product Research Manager, with responsibility for operations and strategy development in the area of new business ventures. In the last years, he managed the production of enzymes and carbohydrates with aevotis GmbH and later evoxx technologies GmbH.
.jpg)
Director at Max Planck Institute DCTS
Prof. Dr. -Ing. Udo Reichl
Prof. Reichl studied biology at Saarland University, and Chemical Engineering at Stuttgart University, where he gained his PhD at the Institute for Systems Dynamic and Control. After holding several postdoc positions, he became head of virus productions at Pitman-Moore GmbH in Burgwedel near Hanover, Germany. Since 1999, he has held the Chair of Bioprocess Engineering at the Otto-von-Guericke University Magdeburg, and he was appointed Director at the MPI for the Dynamics of Complex Technical Systems in 2000.